Event
Seminar
November 14, 2022 @ 11:00 am
CHÉOS Visiting Trainee Seminar: Chrianna Bharat
Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment
Read More
Event
Seminar
November 14, 2022 @ 11:00 am
Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment
Read More
Event
Work in Progress Seminar Series
October 20, 2021 @ 12:00 pm
Emulating target trials to strengthen the evidence base for the clinical management of opioid use disorder
Read More
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read More
This edition includes cannabis use in women with pelvic pain, the association between HPV vaccination and STIs, and anticoagulation for dialysis patients with atrial fibrillation
Read More
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Read More
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read More